RUMORED BUZZ ON CIALIS

In Oct 2007, the FDA introduced that the labeling for all PDE5 inhibitors, including tadalafil, needs a more prominent warning from the opportunity hazard of sudden Listening to loss as the result of post-promoting studies of temporary deafness associated with use of PDE5 inhibitors.[19][8] The FDA concluded they have been unable to attract a induc